Last 12 months
Inside the activity.
4 purchase rows · 0 sale rows
Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.Monthly counts
| Month | Purchases | Sales |
|---|---|---|
| Nov 2025 | 0 | 0 |
| Dec 2025 | 0 | 0 |
| Jan 2026 | 0 | 0 |
| Feb 2026 | 0 | 0 |
| Mar 2026 | 0 | 0 |
| Apr 2026 | 0 | 0 |
| May 2026 | 0 | 0 |
| Jun 2026 | 0 | 0 |
| Jul 2026 | 0 | 0 |
| Aug 2026 | 4 | 0 |
| Sep 2026 | 0 | 0 |
| Oct 2026 | 0 | 0 |
Latest available
Insider transactions
Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Owner / reported role | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| May 21, 2021 Filed May 25, 2021 23:50 UTC |
Niihara YutakaDirector · Chairman and CEO · 10% owner
|
PurchaseCommon stock, $0.001 par value | 2,600 | $1.53 | $3,978.00 |
DisclosureSEC source: 0001209191-21-035813 · doc4.xml · nonDerivative · entry 1 Niihara Yutaka · CIK 0001517691 · Director · Chairman and CEO · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,734,650 F1 · price: The price reported is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $1.53 to $1.60, inclusive. The reporting person undertakes to provide to Emmaus Life Sciences, Inc., any security holder of Emmaus Life Sciences, Inc., and the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote (1) and in footnotes (3) and (4) to this Form 4. F2 · ownership.direct: The shares shown include shares owned jointly with Soomi Niihara, the reporting person's wife. Read SEC document |
| May 19, 2021 Filed May 20, 2021 20:39 UTC |
Niihara YutakaDirector · Chairman and CEO · 10% owner
|
PurchaseCommon stock, $0.001 par value | 4,000 | $1.45 | $5,800.00 |
DisclosureSEC source: 0001209191-21-034436 · doc4.xml · nonDerivative · entry 2 Niihara Yutaka · CIK 0001517691 · Director · Chairman and CEO · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,732,050 F3 · price: The price reported is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $1.43 to $1.50, inclusive. F2 · ownership.direct: The shares shown include shares owned jointly with Soomi Niihara, the reporting person's wife. Read SEC document |
| May 18, 2021 Filed May 20, 2021 20:39 UTC |
Niihara YutakaDirector · Chairman and CEO · 10% owner
|
PurchaseCommon stock, $0.001 par value | 504 | $1.57 | $791.28 |
DisclosureSEC source: 0001209191-21-034436 · doc4.xml · nonDerivative · entry 1 Niihara Yutaka · CIK 0001517691 · Director · Chairman and CEO · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,728,050 F1 · price: The price reported is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $1.50 to $1.60, inclusive. The reporting person undertakes to provide to Emmaus Life Sciences, Inc., any security holder of Emmaus Life Sciences, Inc., and the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote (1) and in footnote (3) to this Form 4. F2 · ownership.direct: The shares shown include shares owned jointly with Soomi Niihara, the reporting person's wife. Read SEC document |
| May 14, 2021 Filed May 14, 2021 22:04 UTC |
Niihara YutakaDirector · Chairman and CEO · 10% owner
|
PurchaseCommon stock, $0.001 par value | 1,300 | $1.48 | $1,924.00 |
DisclosureSEC source: 0001209191-21-032865 · doc4.xml · nonDerivative · entry 3 Niihara Yutaka · CIK 0001517691 · Director · Chairman and CEO · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,727,546 F3 · price: The price reported is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $1.35 to $1.55, inclusive. F1 · ownership.direct: The shares shown include shares owned jointly with Soomi Niihara, the reporting person's wife. Read SEC document |
| May 13, 2021 Filed May 14, 2021 22:04 UTC |
Niihara YutakaDirector · Chairman and CEO · 10% owner
|
PurchaseCommon stock, $0.001 par value | 3,500 | $1.41 | $4,935.00 |
DisclosureSEC source: 0001209191-21-032865 · doc4.xml · nonDerivative · entry 2 Niihara Yutaka · CIK 0001517691 · Director · Chairman and CEO · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,726,246 F2 · price: The price reported is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $1.38 to $1.50, inclusive. The reporting person undertakes to provide to Emmaus Life Sciences, Inc., any security holder of Emmaus Life Sciences, Inc., and the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote (2) and in footnote (3) to this Form 4. F1 · ownership.direct: The shares shown include shares owned jointly with Soomi Niihara, the reporting person's wife. Read SEC document |
| May 12, 2021 Filed May 12, 2021 22:28 UTC |
LEE WILLIS CDirector · Vice Chairman & COO
|
PurchaseCommon stock, $0.001 par value | 13,350 | $1.10 | $14,685.00 |
DisclosureSEC source: 0001209191-21-032183 · doc4.xml · nonDerivative · entry 2 LEE WILLIS C · CIK 0001517775 · Director · Vice Chairman & COO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 242,074 F1 · price: The price reported is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $1.10 to $1.20, inclusive. The reporting person undertakes to provide to Emmaus Life Sciences, Inc., any security holder of Emmaus Life Sciences, Inc., and the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote (1). Read SEC document |
| May 12, 2021 Filed May 14, 2021 22:04 UTC |
Niihara YutakaDirector · Chairman and CEO · 10% owner
|
PurchaseCommon stock, $0.001 par value | 8,000 | $1.10 | $8,800.00 |
DisclosureSEC source: 0001209191-21-032865 · doc4.xml · nonDerivative · entry 1 Niihara Yutaka · CIK 0001517691 · Director · Chairman and CEO · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,722,746 F1 · ownership.direct: The shares shown include shares owned jointly with Soomi Niihara, the reporting person's wife. Read SEC document |
| May 10, 2021 Filed May 10, 2021 21:33 UTC |
Niihara YutakaDirector · Chairman and CEO · 10% owner
|
PurchaseCommon stock, $0.001 par value | 3,000 | $1.15 | $3,450.00 |
DisclosureSEC source: 0001209191-21-031344 · doc4.xml · nonDerivative · entry 3 Niihara Yutaka · CIK 0001517691 · Director · Chairman and CEO · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,714,746 F2 · price: The price reported is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $1.14 to $1.15, inclusive. The reporting person undertakes to provide to Emmaus Life Sciences, Inc., any security holder of Emmaus Life Sciences, Inc., and the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote (2). F1 · ownership.direct: The shares shown include shares owned jointly with Soomi Niihara, the reporting person's wife. Read SEC document |
| May 10, 2021 Filed May 12, 2021 22:28 UTC |
LEE WILLIS CDirector · Vice Chairman & COO
|
PurchaseCommon stock, $0.001 par value | 1,500 | $1.14 | $1,710.00 |
DisclosureSEC source: 0001209191-21-032183 · doc4.xml · nonDerivative · entry 1 LEE WILLIS C · CIK 0001517775 · Director · Vice Chairman & COO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 228,724 Read SEC document |
| May 07, 2021 Filed May 7, 2021 21:27 UTC |
LEE WILLIS CDirector · Vice Chairman & COO
|
PurchaseCommon stock, $0.001 par value | 1,500 | $1.23 | $1,845.00 |
DisclosureSEC source: 0001209191-21-030990 · doc4.xml · nonDerivative · entry 2 LEE WILLIS C · CIK 0001517775 · Director · Vice Chairman & COO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 227,224 F2 · price: The price reported is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $1.19 to $1.23, inclusive. Read SEC document |
| May 07, 2021 Filed May 10, 2021 21:33 UTC |
Niihara YutakaDirector · Chairman and CEO · 10% owner
|
PurchaseCommon stock, $0.001 par value | 2,000 | $1.23 | $2,460.00 |
DisclosureSEC source: 0001209191-21-031344 · doc4.xml · nonDerivative · entry 2 Niihara Yutaka · CIK 0001517691 · Director · Chairman and CEO · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,711,746 F1 · ownership.direct: The shares shown include shares owned jointly with Soomi Niihara, the reporting person's wife. Read SEC document |
| May 06, 2021 Filed May 10, 2021 21:33 UTC |
Niihara YutakaDirector · Chairman and CEO · 10% owner
|
PurchaseCommon stock, $0.001 par value | 1,000 | $1.27 | $1,270.00 |
DisclosureSEC source: 0001209191-21-031344 · doc4.xml · nonDerivative · entry 1 Niihara Yutaka · CIK 0001517691 · Director · Chairman and CEO · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,709,746 F1 · ownership.direct: The shares shown include shares owned jointly with Soomi Niihara, the reporting person's wife. Read SEC document |
| May 05, 2021 Filed May 7, 2021 21:27 UTC |
LEE WILLIS CDirector · Vice Chairman & COO
|
PurchaseCommon stock, $0.001 par value | 2,500 | $1.26 | $3,150.00 |
DisclosureSEC source: 0001209191-21-030990 · doc4.xml · nonDerivative · entry 1 LEE WILLIS C · CIK 0001517775 · Director · Vice Chairman & COO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 225,724 F1 · price: The price reported is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $1.21 to $1.26, inclusive. The reporting person undertakes to provide to Emmaus Life Sciences, Inc., any security holder of Emmaus Life Sciences, Inc., and the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote (1) and in footnote (2) to this Form 4. Read SEC document |
| October 14, 2020 Filed Oct 15, 2020 18:09 UTC |
LEE WILLIS CDirector · Vice Chairman & COO
|
PurchaseCommon stock, $0.001 par value | 1,600 | $0.83 | $1,328.00 |
DisclosureSEC source: 0001209191-20-054870 · doc4.xml · nonDerivative · entry 2 LEE WILLIS C · CIK 0001517775 · Director · Vice Chairman & COO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 223,224 Read SEC document |
| October 14, 2020 Filed Oct 16, 2020 19:33 UTC |
Niihara YutakaDirector · Chairman and CEO · 10% owner
|
PurchaseCommon stock, $0.001 par value | 1,000 | $0.83 | $830.00 |
DisclosureSEC source: 0001209191-20-055032 · doc4.xml · nonDerivative · entry 1 Niihara Yutaka · CIK 0001517691 · Director · Chairman and CEO · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,708,746 F1 · ownership.direct: The shares shown include shares owned jointly with Soomi Niihara, the reporting person's wife. Read SEC document |
| October 13, 2020 Filed Oct 13, 2020 19:32 UTC |
Niihara YutakaDirector · Chairman and CEO · 10% owner
|
PurchaseCommon stock, $0.001 par value | 3,000 | $0.86 | $2,580.00 |
DisclosureSEC source: 0001209191-20-054606 · doc4.xml · nonDerivative · entry 3 Niihara Yutaka · CIK 0001517691 · Director · Chairman and CEO · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,707,746 F2 · price: The price reported is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $0.84 to $0.88, inclusive. The reporting person undertakes to provide to Emmaus Life Sciences, Inc., any security holder of Emmaus Life Sciences, Inc., and the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote (2). F1 · ownership.direct: The shares shown include shares owned jointly with Soomi Niihara, the reporting person's wife. Read SEC document |
| October 13, 2020 Filed Oct 15, 2020 18:09 UTC |
LEE WILLIS CDirector · Vice Chairman & COO
|
PurchaseCommon stock, $0.001 par value | 6,000 | $0.84 | $5,040.00 |
DisclosureSEC source: 0001209191-20-054870 · doc4.xml · nonDerivative · entry 1 LEE WILLIS C · CIK 0001517775 · Director · Vice Chairman & COO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 221,624 Read SEC document |
| October 12, 2020 Filed Oct 13, 2020 19:32 UTC |
Niihara YutakaDirector · Chairman and CEO · 10% owner
|
PurchaseCommon stock, $0.001 par value | 1,000 | $0.90 | $900.00 |
DisclosureSEC source: 0001209191-20-054606 · doc4.xml · nonDerivative · entry 2 Niihara Yutaka · CIK 0001517691 · Director · Chairman and CEO · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,704,746 F1 · ownership.direct: The shares shown include shares owned jointly with Soomi Niihara, the reporting person's wife. Read SEC document |
| October 09, 2020 Filed Oct 13, 2020 19:32 UTC |
Niihara YutakaDirector · Chairman and CEO · 10% owner
|
PurchaseCommon stock, $0.001 par value | 500 | $0.98 | $490.00 |
DisclosureSEC source: 0001209191-20-054606 · doc4.xml · nonDerivative · entry 1 Niihara Yutaka · CIK 0001517691 · Director · Chairman and CEO · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,703,746 F1 · ownership.direct: The shares shown include shares owned jointly with Soomi Niihara, the reporting person's wife. Read SEC document |
| October 08, 2020 Filed Oct 9, 2020 16:37 UTC |
Niihara YutakaDirector · Chairman and CEO · 10% owner
|
PurchaseCommon stock, $0.001 par value | 500 | $1.00 | $500.00 |
DisclosureSEC source: 0001209191-20-054388 · doc4.xml · nonDerivative · entry 2 Niihara Yutaka · CIK 0001517691 · Director · Chairman and CEO · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,703,246 F1 · ownership.direct: The shares shown include shares owned jointly with Soomi Niihara, the reporting person's wife. Read SEC document |
| October 07, 2020 Filed Oct 9, 2020 16:37 UTC |
Niihara YutakaDirector · Chairman and CEO · 10% owner
|
PurchaseCommon stock, $0.001 par value | 1,000 | $1.03 | $1,030.00 |
DisclosureSEC source: 0001209191-20-054388 · doc4.xml · nonDerivative · entry 1 Niihara Yutaka · CIK 0001517691 · Director · Chairman and CEO · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,702,746 F1 · ownership.direct: The shares shown include shares owned jointly with Soomi Niihara, the reporting person's wife. Read SEC document |
| October 06, 2020 Filed Oct 7, 2020 16:19 UTC |
Niihara YutakaDirector · Chairman and CEO · 10% owner
|
PurchaseCommon stock, $0.001 par value | 2,000 | $0.92 | $1,840.00 |
DisclosureSEC source: 0001209191-20-054101 · doc4.xml · nonDerivative · entry 2 Niihara Yutaka · CIK 0001517691 · Director · Chairman and CEO · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,701,746 F1 · ownership.direct: The shares shown include shares owned jointly with Soomi Niihara, the reporting person's wife. Read SEC document |
| October 05, 2020 Filed Oct 7, 2020 16:19 UTC |
Niihara YutakaDirector · Chairman and CEO · 10% owner
|
PurchaseCommon stock, $0.001 par value | 1,250 | $0.96 | $1,200.00 |
DisclosureSEC source: 0001209191-20-054101 · doc4.xml · nonDerivative · entry 1 Niihara Yutaka · CIK 0001517691 · Director · Chairman and CEO · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,699,746 F1 · ownership.direct: The shares shown include shares owned jointly with Soomi Niihara, the reporting person's wife. Read SEC document |
| October 01, 2020 Filed Oct 1, 2020 21:07 UTC |
Niihara YutakaDirector · Chairman and CEO · 10% owner
|
PurchaseCommon stock, $0.001 par value | 6,500 | $1.00 | $6,500.00 |
DisclosureSEC source: 0001209191-20-052671 · doc4.xml · nonDerivative · entry 2 Niihara Yutaka · CIK 0001517691 · Director · Chairman and CEO · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,698,496 F2 · price: The price reported is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $0.99 to $1.00, inclusive. The reporting person undertakes to provide to Emmaus Life Sciences, Inc., any security holder of Emmaus Life Sciences, Inc., and the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote (2). F1 · ownership.direct: The shares shown include shares owned jointly with Soomi Niihara, the reporting person's wife. Read SEC document |
| September 29, 2020 Filed Oct 1, 2020 21:07 UTC |
Niihara YutakaDirector · Chairman and CEO · 10% owner
|
PurchaseCommon stock, $0.001 par value | 3,250 | $0.98 | $3,185.00 |
DisclosureSEC source: 0001209191-20-052671 · doc4.xml · nonDerivative · entry 1 Niihara Yutaka · CIK 0001517691 · Director · Chairman and CEO · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,691,996 F1 · ownership.direct: The shares shown include shares owned jointly with Soomi Niihara, the reporting person's wife. Read SEC document |
| September 28, 2020 Filed Sep 29, 2020 19:04 UTC |
Niihara YutakaDirector · Chairman and CEO · 10% owner
|
PurchaseCommon stock, $0.001 par value | 2,500 | $1.01 | $2,525.00 |
DisclosureSEC source: 0001209191-20-052310 · doc4.xml · nonDerivative · entry 2 Niihara Yutaka · CIK 0001517691 · Director · Chairman and CEO · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,688,746 F2 · price: The price reported is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $1.00 to $1.01, inclusive. The reporting person undertakes to provide to Emmaus Life Sciences, Inc., any security holder of Emmaus Life Sciences, Inc., and the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote (2). F1 · ownership.direct: The shares shown include shares owned jointly with Soomi Niihara, the reporting person's wife. Read SEC document |
| September 25, 2020 Filed Sep 29, 2020 19:04 UTC |
Niihara YutakaDirector · Chairman and CEO · 10% owner
|
PurchaseCommon stock, $0.001 par value | 1,000 | $1.03 | $1,030.00 |
DisclosureSEC source: 0001209191-20-052310 · doc4.xml · nonDerivative · entry 1 Niihara Yutaka · CIK 0001517691 · Director · Chairman and CEO · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,686,246 F1 · ownership.direct: The shares shown include shares owned jointly with Soomi Niihara, the reporting person's wife. Read SEC document |
| September 21, 2020 Filed Sep 23, 2020 21:12 UTC |
Niihara YutakaDirector · Chairman and CEO · 10% owner
|
PurchaseCommon stock, $0.001 par value | 500 | $1.20 | $600.00 |
DisclosureSEC source: 0001209191-20-051685 · doc4.xml · nonDerivative · entry 1 Niihara Yutaka · CIK 0001517691 · Director · Chairman and CEO · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,685,246 F1 · price: The price reported is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $1.18 to $1.21, inclusive. The reporting person undertakes to provide to Emmaus Life Sciences, Inc., any security holder of Emmaus Life Sciences, Inc., and the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote (1). F2 · ownership.direct: The shares shown include shares owned jointly with Soomi Niihara, the reporting person's wife. Read SEC document |
| September 17, 2020 Filed Sep 21, 2020 22:48 UTC |
Niihara YutakaDirector · Chairman and CEO · 10% owner
|
PurchaseCommon stock, $0.001 par value | 300 | $1.30 | $390.00 |
DisclosureSEC source: 0001209191-20-051370 · doc4.xml · nonDerivative · entry 1 Niihara Yutaka · CIK 0001517691 · Director · Chairman and CEO · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,684,746 F1 · ownership.direct: The shares shown include shares owned jointly with Soomi Niihara, the reporting person's wife. Read SEC document |
| September 15, 2020 Filed Sep 17, 2020 20:22 UTC |
Niihara YutakaDirector · Chairman and CEO · 10% owner
|
PurchaseCommon stock, $0.001 par value | 1,000 | $1.20 | $1,200.00 |
DisclosureSEC source: 0001209191-20-050892 · doc4.xml · nonDerivative · entry 1 Niihara Yutaka · CIK 0001517691 · Director · Chairman and CEO · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,684,446 F1 · ownership.direct: The shares shown include shares owned jointly with Soomi Niihara, the reporting person's wife. Read SEC document |
| September 11, 2020 Filed Sep 15, 2020 18:09 UTC |
Niihara YutakaDirector · Chairman and CEO · 10% owner
|
PurchaseCommon stock, $0.001 par value | 1,500 | $1.19 | $1,785.00 |
DisclosureSEC source: 0001209191-20-050438 · doc4.xml · nonDerivative · entry 1 Niihara Yutaka · CIK 0001517691 · Director · Chairman and CEO · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,683,446 F1 · price: The price reported is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $1.19 to $1.20, inclusive. The reporting person undertakes to provide to Emmaus Life Sciences, Inc., any security holder of Emmaus Life Sciences, Inc., and the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote (1). F2 · ownership.direct: The shares shown include shares owned jointly with Soomi Niihara, the reporting person's wife. Read SEC document |
| September 08, 2020 Filed Sep 10, 2020 21:54 UTC |
Niihara YutakaDirector · Chairman and CEO · 10% owner
|
PurchaseCommon stock, $0.001 par value | 1,000 | $1.25 | $1,250.00 |
DisclosureSEC source: 0001209191-20-050021 · doc4.xml · nonDerivative · entry 1 Niihara Yutaka · CIK 0001517691 · Director · Chairman and CEO · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,681,946 F1 · ownership.direct: The shares shown include shares owned jointly with Soomi Niihara, the reporting person's wife. Read SEC document |
| September 03, 2020 Filed Sep 4, 2020 20:00 UTC |
Niihara YutakaDirector · Chairman and CEO · 10% owner
|
PurchaseCommon stock, $0.001 par value | 1,300 | $1.33 | $1,729.00 |
DisclosureSEC source: 0001209191-20-049605 · doc4.xml · nonDerivative · entry 2 Niihara Yutaka · CIK 0001517691 · Director · Chairman and CEO · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,680,946 F3 · price: The price reported is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $1.29 to $1.39, inclusive. F2 · ownership.direct: The shares shown include shares owned jointly with Soomi Niihara, the reporting person's wife. Read SEC document |
| September 02, 2020 Filed Sep 4, 2020 20:00 UTC |
Niihara YutakaDirector · Chairman and CEO · 10% owner
|
PurchaseCommon stock, $0.001 par value | 650 | $1.44 | $936.00 |
DisclosureSEC source: 0001209191-20-049605 · doc4.xml · nonDerivative · entry 1 Niihara Yutaka · CIK 0001517691 · Director · Chairman and CEO · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,679,646 F1 · price: The price reported is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $1.43 to $1.45, inclusive. The reporting person undertakes to provide to Emmaus Life Sciences, Inc., any security holder of Emmaus Life Sciences, Inc., and the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote (1) and in footnote (3) to this Form 4. F2 · ownership.direct: The shares shown include shares owned jointly with Soomi Niihara, the reporting person's wife. Read SEC document |
| August 26, 2020 Filed Aug 27, 2020 18:02 UTC |
Niihara YutakaDirector · Chairman and CEO · 10% owner
|
PurchaseCommon stock, $0.001 par value | 250 | $1.59 | $397.50 |
DisclosureSEC source: 0001209191-20-048501 · doc4.xml · nonDerivative · entry 2 Niihara Yutaka · CIK 0001517691 · Director · Chairman and CEO · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,678,996 F1 · ownership.direct: The shares shown include shares owned jointly with Soomi Niihara, the reporting person's wife. Read SEC document |
| August 25, 2020 Filed Aug 27, 2020 18:02 UTC |
Niihara YutakaDirector · Chairman and CEO · 10% owner
|
PurchaseCommon stock, $0.001 par value | 500 | $1.60 | $800.00 |
DisclosureSEC source: 0001209191-20-048501 · doc4.xml · nonDerivative · entry 1 Niihara Yutaka · CIK 0001517691 · Director · Chairman and CEO · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,678,746 F1 · ownership.direct: The shares shown include shares owned jointly with Soomi Niihara, the reporting person's wife. Read SEC document |
| August 21, 2020 Filed Aug 25, 2020 17:29 UTC |
Niihara YutakaDirector · Chairman and CEO · 10% owner
|
PurchaseCommon stock, $0.001 par value | 250 | $1.59 | $397.50 |
DisclosureSEC source: 0001209191-20-048199 · doc4.xml · nonDerivative · entry 1 Niihara Yutaka · CIK 0001517691 · Director · Chairman and CEO · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,678,246 F1 · price: The price reported is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $1.59 to $1.60, inclusive. The reporting person undertakes to provide to Emmaus Life Sciences, Inc., any security holder of Emmaus Life Sciences, Inc., and the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote (1). F2 · ownership.direct: The shares shown include shares owned jointly with Soomi Niihara, the reporting person's wife. Read SEC document |
| August 20, 2020 Filed Aug 21, 2020 16:56 UTC |
Niihara YutakaDirector · Chairman and CEO · 10% owner
|
PurchaseCommon stock, $0.001 par value | 500 | $1.55 | $775.00 |
DisclosureSEC source: 0001209191-20-047885 · doc4.xml · nonDerivative · entry 2 Niihara Yutaka · CIK 0001517691 · Director · Chairman and CEO · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,677,996 F1 · ownership.direct: The shares shown include shares owned jointly with Soomi Niihara, the reporting person's wife. Read SEC document |
| August 19, 2020 Filed Aug 21, 2020 16:56 UTC |
Niihara YutakaDirector · Chairman and CEO · 10% owner
|
PurchaseCommon stock, $0.001 par value | 100 | $1.56 | $156.00 |
DisclosureSEC source: 0001209191-20-047885 · doc4.xml · nonDerivative · entry 1 Niihara Yutaka · CIK 0001517691 · Director · Chairman and CEO · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,677,496 F1 · ownership.direct: The shares shown include shares owned jointly with Soomi Niihara, the reporting person's wife. Read SEC document |
| August 18, 2020 Filed Aug 19, 2020 17:55 UTC |
Niihara YutakaDirector · Chairman and CEO · 10% owner
|
PurchaseCommon stock, $0.001 par value | 250 | $1.57 | $392.50 |
DisclosureSEC source: 0001209191-20-047452 · doc4.xml · nonDerivative · entry 2 Niihara Yutaka · CIK 0001517691 · Director · Chairman and CEO · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,677,396 F2 · ownership.direct: The shares shown include shares owned jointly with Soomi Niihara, the reporting person's wife. Read SEC document |
| August 17, 2020 Filed Aug 19, 2020 17:55 UTC |
Niihara YutakaDirector · Chairman and CEO · 10% owner
|
PurchaseCommon stock, $0.001 par value | 1,000 | $1.62 | $1,620.00 |
DisclosureSEC source: 0001209191-20-047452 · doc4.xml · nonDerivative · entry 1 Niihara Yutaka · CIK 0001517691 · Director · Chairman and CEO · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,677,146 F1 · price: The price reported is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $1.59 to $1.64, inclusive. The reporting person undertakes to provide to Emmaus Life Sciences, Inc., any security holder of Emmaus Life Sciences, Inc., and the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote (1). F2 · ownership.direct: The shares shown include shares owned jointly with Soomi Niihara, the reporting person's wife. Read SEC document |
| August 14, 2020 Filed Aug 17, 2020 16:37 UTC |
Niihara YutakaDirector · Chairman and CEO · 10% owner
|
PurchaseCommon stock, $0.001 par value | 500 | $1.59 | $795.00 |
DisclosureSEC source: 0001209191-20-046906 · doc4.xml · nonDerivative · entry 2 Niihara Yutaka · CIK 0001517691 · Director · Chairman and CEO · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,676,146 F3 · price: The price reported is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $1.54 to $1.64, inclusive. F2 · ownership.direct: The shares shown include shares owned jointly with Soomi Niihara, the reporting person's wife. Read SEC document |
| August 13, 2020 Filed Aug 17, 2020 16:37 UTC |
Niihara YutakaDirector · Chairman and CEO · 10% owner
|
PurchaseCommon stock, $0.001 par value | 1,100 | $1.46 | $1,606.00 |
DisclosureSEC source: 0001209191-20-046906 · doc4.xml · nonDerivative · entry 1 Niihara Yutaka · CIK 0001517691 · Director · Chairman and CEO · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,675,646 F1 · price: The price reported is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $1.45 to $1.47, inclusive. The reporting person undertakes to provide to Emmaus Life Sciences, Inc., any security holder of Emmaus Life Sciences, Inc., and the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote (1) and in footnote (3) to this Form 4. F2 · ownership.direct: The shares shown include shares owned jointly with Soomi Niihara, the reporting person's wife. Read SEC document |
| August 12, 2020 Filed Aug 13, 2020 16:02 UTC |
Niihara YutakaDirector · Chairman and CEO · 10% owner
|
PurchaseCommon stock, $0.001 par value | 850 | $1.53 | $1,300.50 |
DisclosureSEC source: 0001209191-20-046538 · doc4.xml · nonDerivative · entry 2 Niihara Yutaka · CIK 0001517691 · Director · Chairman and CEO · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,674,546 F3 · price: The price reported is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $1.50 to $1.54, inclusive. F2 · ownership.direct: The shares shown include shares owned jointly with Soomi Niihara, the reporting person's wife. Read SEC document |
| August 11, 2020 Filed Aug 13, 2020 16:02 UTC |
Niihara YutakaDirector · Chairman and CEO · 10% owner
|
PurchaseCommon stock, $0.001 par value | 303 | $1.87 | $566.61 |
DisclosureSEC source: 0001209191-20-046538 · doc4.xml · nonDerivative · entry 1 Niihara Yutaka · CIK 0001517691 · Director · Chairman and CEO · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,673,696 F1 · price: The price reported is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $1.59 to $1.93, inclusive. The reporting person undertakes to provide to Emmaus Life Sciences, Inc., any security holder of Emmaus Life Sciences, Inc., and the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote (1) and in footnote (3) to this Form 4. F2 · ownership.direct: The shares shown include shares owned jointly with Soomi Niihara, the reporting person's wife. Read SEC document |
| June 19, 2020 Filed Jun 23, 2020 17:42 UTC |
Niihara YutakaDirector · Chairman and CEO · 10% owner
|
PurchaseCommon stock, $0.001 par value | 1,200 | $1.74 | $2,088.00 |
DisclosureSEC source: 0001209191-20-038401 · doc4.xml · nonDerivative · entry 1 Niihara Yutaka · CIK 0001517691 · Director · Chairman and CEO · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,673,393 F1 · price: The price reported is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $1.73 to $1.75, inclusive. The reporting person undertakes to provide to Emmaus Life Sciences, Inc., any security holder of Emmaus Life Sciences, Inc., and the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote (1). F2 · ownership.direct: The shares shown include shares owned jointly with Soomi Niihara, the reporting person's wife. Read SEC document |
| June 16, 2020 Filed Jun 18, 2020 16:20 UTC |
Niihara YutakaDirector · Chairman and CEO · 10% owner
|
PurchaseCommon stock, $0.001 par value | 1,000 | $1.67 | $1,670.00 |
DisclosureSEC source: 0001209191-20-037529 · doc4.xml · nonDerivative · entry 1 Niihara Yutaka · CIK 0001517691 · Director · Chairman and CEO · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,672,193 F1 · price: The price reported is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $1.65 to $1.67, inclusive. The reporting person undertakes to provide to Emmaus Life Sciences, Inc., any security holder of Emmaus Life Sciences, Inc., and the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote (1). F2 · ownership.direct: The shares shown include shares owned jointly with Soomi Niihara, the reporting person's wife. Read SEC document |
| June 15, 2020 Filed Jun 16, 2020 17:37 UTC |
Niihara YutakaDirector · Chairman and CEO · 10% owner
|
PurchaseCommon stock, $0.001 par value | 500 | $1.67 | $835.00 |
DisclosureSEC source: 0001209191-20-036922 · doc4.xml · nonDerivative · entry 2 Niihara Yutaka · CIK 0001517691 · Director · Chairman and CEO · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,671,193 F3 · price: The price reported is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $1.66 to $1.69, inclusive. F2 · ownership.direct: The shares shown include shares owned jointly with Soomi Niihara, the reporting person's wife. Read SEC document |
| June 12, 2020 Filed Jun 16, 2020 17:37 UTC |
Niihara YutakaDirector · Chairman and CEO · 10% owner
|
PurchaseCommon stock, $0.001 par value | 1,000 | $1.67 | $1,670.00 |
DisclosureSEC source: 0001209191-20-036922 · doc4.xml · nonDerivative · entry 1 Niihara Yutaka · CIK 0001517691 · Director · Chairman and CEO · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,670,693 F1 · price: The price reported is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $1.65 to $1.69, inclusive. The reporting person undertakes to provide to Emmaus Life Sciences, Inc., any security holder of Emmaus Life Sciences, Inc., and the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote (1) and in footnote (3) to this Form 4. F2 · ownership.direct: The shares shown include shares owned jointly with Soomi Niihara, the reporting person's wife. Read SEC document |
| June 11, 2020 Filed Jun 12, 2020 20:16 UTC |
Niihara YutakaDirector · Chairman and CEO · 10% owner
|
PurchaseCommon stock, $0.001 par value | 4,800 | $1.75 | $8,400.00 |
DisclosureSEC source: 0001209191-20-036254 · doc4.xml · nonDerivative · entry 2 Niihara Yutaka · CIK 0001517691 · Director · Chairman and CEO · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,669,693 F3 · price: The price reported is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $1.69 to $1.78, inclusive. F2 · ownership.direct: The shares shown include shares owned jointly with Soomi Niihara, the reporting person's wife. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.